Difference between revisions of "PCC TC Face to Face July 22 26, 2019 Minutes"
Jump to navigation
Jump to search
Line 81: | Line 81: | ||
**Consensus | **Consensus | ||
***A detailed proposal is needed | ***A detailed proposal is needed | ||
− | *** | + | ***IHE can produce for this cycle a very basic document with two options: test plan or content profile |
***Agenda could be : Vol1 in November, Vol2 in February, Review of public comments in April | ***Agenda could be : Vol1 in November, Vol2 in February, Review of public comments in April | ||
**Voting session | **Voting session | ||
*** 4 : Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé) | *** 4 : Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé) | ||
*** One motion from Tone Southerland (4 in favour, 0 abstention) : have more details in a detailed proposal in a fex weeks to be reviewed during PCC T-Conf (bi-weekly) | *** One motion from Tone Southerland (4 in favour, 0 abstention) : have more details in a detailed proposal in a fex weeks to be reviewed during PCC T-Conf (bi-weekly) |
Revision as of 05:01, 25 July 2019
Monday July 22, 2019
- Attendees
- In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- Review Anti-trust and Patent Policy
- Format codes
- Format codes IHE and HL7 have their own format codes
- There is a lot of confusion for a vendor perspective between format codes and template ID
- Shall PCC work on a profile to manage this ?
- Agenda update see PCC_TC_Face_to_Face_July_22-26,_2019
- DCP and CDA-DSS (review of public comments)
- IPS-International Patient Summary (Profil proposal)
- Website [3]
- Attendees: same +
- In Person: Lori Fourquet, Derek,
- Via Webex: Michael Nusbaum
- IHE PCC TC questions
- 1)Scope of workflow
- 2)Benefits for vendor (risks
- 3)Marketing
- Next steps
- IHE PCC TC needs more detail about this proposal.
- Is there any additional stake holder ?
- Who is responsible of what (HL7/IHE)?
Tuesday July 23, 2019
- Attendees
- In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- DCP and CDA-DSS (review of public comments)
- DCP public comments
- C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-46: Persuasive
- C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff
- C-47, C-48: Non persuasive
- C-49, C-52: Hold for now
- C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
- C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions
- CDA-DSS public comments
- C-01 to C-03, C-05 to C-10: persuasive
- C-04: non persuasive
- DCP public comments
- IPS-International Patient Summary (Profil proposal)
- Attendees: same +
- In Person: Lori Fourquet, Tone Southerland (IQVIA)
- Attendees: same +
Wednesday July 24, 2019
- Attendees
- In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- DCP and CDA-DSS (review of public comments)
- DCP public comments
- DCP public comments will be reviewed on the next PCC T-Conf, because Emma needs some inputs from Jeff and Steve.
- DCP public comments
- CDA-DSS public comments
- All the commets have been reviewed.
- Updated version of DCP is on the FTP site.
- CDA-DSS public comments
- IPS-International Patient Summary (Profil proposal)
- Attendees: same +
- In Person: Lori Fourquet, Tone Southerland (IQVIA), Derek Ritz,
- Consensus
- A detailed proposal is needed
- IHE can produce for this cycle a very basic document with two options: test plan or content profile
- Agenda could be : Vol1 in November, Vol2 in February, Review of public comments in April
- Voting session
- 4 : Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
- One motion from Tone Southerland (4 in favour, 0 abstention) : have more details in a detailed proposal in a fex weeks to be reviewed during PCC T-Conf (bi-weekly)
- Attendees: same +